Clinical Pharmacokinetics of Drugs Used in the Treatment of Gastrointestinal Diseases (Part II)
- 1 August 1990
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 19 (2) , 94-125
- https://doi.org/10.2165/00003088-199019020-00002
Abstract
Part I of this article, which appeared in the previous issue of the Journal, covered the following agents: histamine H2-receptor antagonists (cimetidine, ranitidine, famotidine, nizatidine); muscarinic-M1 -receptor antagonists (pirenzepine); proton pump inhibitors (omeprazole); site-protective agents (colloidal bismuth subcitrate, sucralfate); antacids and prostaglandin analogues; antiemetics and prokinetics (metoclopramide, domperidone, cisapride); and antispasmodics. In Part II, we consider the anti-inflammatory salicylates, nonspecific antidiarrhoeal agents, laxatives and cathartics.Keywords
This publication has 98 references indexed in Scilit:
- RanitidineDrugs, 1989
- Interaction of Diazepam With Famotidine and Cimetidine, Two H2‐Receptor AntagonistsThe Journal of Clinical Pharmacology, 1986
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Human Pharmacokinetics and Comparative Bioavailability of Loperamide HydrochlorideThe Journal of Clinical Pharmacology, 1979
- CimetidineDrugs, 1978
- LoperamideDrugs, 1978
- Radioimmunoassay of the antidiarrhoeal loperamideLife Sciences, 1977
- Antacid Therapy and Drug Kinetics1Clinical Pharmacokinetics, 1977
- MetoclopramideDrugs, 1976
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976